Additional file 1 of Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen

Additional file 1. File excel composed by 4 sheets. Table S1. All DE. Differentially expressed cfRNAs in “all” SMA patients at T4 versus T0 nusinersen injection. Gene name, gene biotype and measured log2FC are reported for each transcript. Only transcripts with |log2(T4/T0l)|≥ 0.5 and a FDR ≤ 0.1 are shown. Table S2. Heterogeneous DE. Differentially expressed cfRNAs in “heterogeneous” SMA patients at T4 versus T0 nusinersen injection. Gene name, gene biotype and measured log2FC are reported for each transcript. Only transcripts with |log2(T4/T0l)|≥ 0.5 and a FDR ≤ 0.1 are sown. Table S3. Homogeneous DE. Differentially expressed cfRNAs in "homogeneous" SMA patients at T4 versus T0 nusinersen injection. Gene name, gene biotype and measured log2FC are reported for each transcript. Only transcripts with |log2(T4/T0l)|≥ 0.5 and a FDR ≤ 0.1 are shown. Table S4. Venn Results. Venn analysis of DE cfRNAs in “all”, “heterogeneous” and “homogeneous” groups.